• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Deutsch 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Einloggen
Dokumentanzeige 
  •   DSpace Startseite
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Dokumentanzeige
  •   DSpace Startseite
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Dokumentanzeige
JavaScript is disabled for your browser. Some features of this site may not work without it.
Gesamter Bestand
  • Bereiche & Sammlungen
  • Erscheinungsdatum
  • Autoren
  • Titeln
  • Schlagworten

Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010–2020)

Thumbnail
Autor
Xirogianni A., Marmaras N., Georgakopoulou T., Papandreou A., Simantirakis S., Magaziotou I., Eliades A., Getsi V., Anastasiou-Katsiardani A., Staikou E., Markou F., Argyrοpoulou A., Vlachaki G., Chronopoulou G., Pangalis A., Liakopoulou T., Michos A., Spoulou V., Lagona E., Panagiotakopoulos G., Petinaki E., Mantadakis E., Roilides E., Galanakis M., Papaevangelou V., Tsolia M., Tzanakaki G.
Datum
2022
Language
en
DOI
10.1016/j.vaccine.2022.07.015
Schlagwort
Pneumococcus vaccine
vaccine
aged
Greece
human
infant
microbiology
pneumococcal infection
pneumococcal meningitis
retrospective study
serotype
serotyping
Streptococcus pneumoniae
Aged
Greece
Humans
Infant
Meningitis, Pneumococcal
Pneumococcal Infections
Pneumococcal Vaccines
Retrospective Studies
Serogroup
Serotyping
Streptococcus pneumoniae
Vaccines, Conjugate
Elsevier Ltd
Zur Langanzeige
Zusammenfassung
Background: As Greece is a country which has introduced the 13-valent pneumococcal conjugate vaccine (PCV13) both in the infant and in the adult immunization programs, the aim of the study was to investigate age-specific and serotype-specific trends of pneumococcal meningitis over an 11-year period (2010–2020). Materials and Methods: Data are reported from pneumococcal meningitis cases [notified to the National Public Health Organization (NPHO)], with clinical samples and bacterial isolates sent for pneumococcal identification and serotyping at the National Meningitis Reference Laboratory (NMRL). Pneumococcal identification was performed directly on clinical samples or bacterial isolates by multiplex PCR (mPCR) assay, while serotyping was carried out by application of the Capsular Sequence Typing (CST) method with the combination of single tube PCR assays. Results: A total of 427 pneumococcal meningitis cases were notified to the NPHO between 2010 and 2020. Among those, 405 (94.8%) were microbiologically confirmed, while samples from 273 patients were sent to the NMRL for identification and/or further typing. The annual notification rate peaked at 0.47/100,000 in 2016 and since then has been decreasing. The incidence was highest in infants and in older adults. Pneumococcal serotypes were identified in 260/273 (95.2%) cases, where clinical samples were sent to the NMRL. The most prevalent serotypes (≥5%) were 3, 19A, 23B, 15B/C, 11A/D, 23A, 22F. During the study period there has been a decrease of PCV13 serotypes combined with an increase of non-PCV13 serotypes (p = 0.0045). Conclusions: This is the first study to report serotypes for pneumococcal meningitis across all ages in the post-PCV13 era in Greece. There is a need to enhance surveillance, by close monitoring of the emerging serotypes and the impact of vaccination programs. Higher-valency PCVs may help to improve the coverage of pneumococcal disease. © 2022 Elsevier Ltd
URI
http://hdl.handle.net/11615/80852
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]

Verwandte Dokumente

Anzeige der Dokumente mit ähnlichem Titel, Autor, Urheber und Thema.

  • Thumbnail

    Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule 

    Syrogiannopoulos G.A., Grivea I.N., Moriondo M., Nieddu F., Michoula A.N., Calabrese M.R., Anthracopoulos M., Azzari C. (2021)
    In a cross-sectional study, with the use of molecular methods, we aimed to gain insight into oropharyngeal pneumococcal colonization over time in 1212 Greek children recruited in general pediatric settings throughout the ...
  • Thumbnail

    Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine 

    Syrogiannopoulos G.A., Michoula A.N., Tsimitselis G., Vassiou K., Chryssanthopoulou D.C., Grivea I.N. (2016)
    Abstract: Background: Parapneumonic effusions in children are usually associated with pneumococcal infections. In Greece, the 7-valent pneumococcal conjugate vaccine was replaced by higher-valent pneumococcal conjugate ...
  • Thumbnail

    Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece 

    Grivea, I. N.; Priftis, K. N.; Giotas, A.; Kotzia, D.; Tsantouli, A. G.; Douros, K.; Michoula, A. N.; Syrogiannopoulos, G. A. (2014)
    Background: In Greece recently, higher-valent pneumococcal conjugate vaccines (PCVs) replaced the 7-valent (PCV7); the 10-valent (PCV10) became available in May 2009 and the 13-valent (PCV13) in June 2010. Methods: We ...
htmlmap 

 

Stöbern

Gesamter BestandBereiche & SammlungenErscheinungsdatumAutorenTitelnSchlagwortenDiese SammlungErscheinungsdatumAutorenTitelnSchlagworten

Mein Benutzerkonto

EinloggenRegistrieren
Help Contact
DepositionAboutHelpKontakt
Choose LanguageGesamter Bestand
EnglishΕλληνικά
htmlmap